TSW
PAHC icon

Thompson Siegel & Walmsley’s Phibro Animal Health PAHC Stock Holding History

Thompson Siegel & Walmsley’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-11,100
Closed -$300K – 804
2016
Q1 		$300K Sell
11,100
-5,450
-33% -$156K ﹤0.01% 354
2015
Q4 		$499K Buy
16,550
+5,400
+48% +$173K 0.01% 323
2015
Q3 		$353K Buy
11,150
+1,000
+10% +$36.5K 0.01% 348
2015
Q2 		$395K Sell
10,150
-1,850
-15% -$63.8K 0.01% 346
2015
Q1 		$425K Buy
12,000
+2,900
+32% +$93.4K 0.01% 341
2014
Q4 		$287K Buy
+9,100
New +$252K 0.01% 369

Other funds holding PAHC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $10.5B AUM 30.38% 1-Year Est. Return
VFA
Virtus Fund Advisers Hartford, Connecticut $32.1M AUM 39.5% 1-Year Est. Return
FIM
Foresters Investment Management New York $5.05B AUM 5.06% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
DIA
Denver Investment Advisors Denver, Colorado $1.89B AUM 7.9% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Thompson Siegel & Walmsley's PAHC Position: Q2 2016 in Review

Thompson Siegel & Walmsley sold out of Phibro Animal Health (PAHC) in Q2 2016, closing a stake of 11,100 shares — an estimated $300K sold.

Thompson Siegel & Walmsley first reported a position in PAHC in Q4 2014 and held it in 6 quarters. The position peaked at $499K in Q4 2015. 123 funds tracked by Wall St. Rank hold PAHC as of Q2 2016.

  • Thompson Siegel & Walmsley reported no remaining Phibro Animal Health position as of Q2 2016 after selling out during the quarter.
  • Thompson Siegel & Walmsley sold 11,100 Phibro Animal Health shares in Q2 2016, an estimated $300K.
  • Thompson Siegel & Walmsley first reported a position in Phibro Animal Health in Q4 2014 and held it in 6 quarters.
  • Thompson Siegel & Walmsley's Phibro Animal Health position peaked at $499K in Q4 2015.
  • 123 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2016.

Based on Thompson Siegel & Walmsley's 13F filing for Q2 2016, filed 5 Aug 2016.